Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Involvement of EGFR in the promotion of malignant properties in multidrug resistant breast cancer cells.

International journal of oncology - 1 Dec 2011

Xu Jia-Wen, Li Qing-Quan, Tao Li-Li, Cheng Yuan-Yuan, Yu Juan, Chen Qi, Liu Xiu-Ping, Xu Zu-De

Abstract excerpt

Multidrug resistance is the most predominant phenomenon leading to chemotherapy treatment failure in breast cancer patients. Despite many studies having suggested that overexpression of epidermal growth factor receptor (EGFR) is a potent predictor of malignancy in cancers, systematic research of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Basigin
Share to Cyclin D1
Share to Cyclin-Dependent Kinase 4

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclin-Dependent Kinase Inhibitor p21

Share to Cyclin-Dependent Kinase Inhibitor p27

Share to Drug Resistance, Multiple

Share to Matrix Metalloproteinase 2

Share to Matrix Metalloproteinase 9

Source

Identifiers

PMID: 21805028
DOI: 10.3892/ijo.2011.1143

Genes

EGFR
ABCG2
CDK4
MMP2
MMP9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21805028-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Involvement of EGFR in the promotion of malignant properties in multidrug resistant breast cancer cells.PMID 21805028Read ↗

EGFR-mediated G1/S transition contributes to the multidrug resistance in breast cancer cells.Semantic proximity Read ↗

EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review)Semantic proximity Read ↗

Estrogen Enhances the Expression of the Multidrug Transporter Gene ABCG2—Increasing Drug Resistance of Breast Cancer Cells through Estrogen ReceptorsSemantic proximity Read ↗

Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cellsSemantic proximity Read ↗

Exosomes play an important role in the process of psoralen reverse multidrug resistance of breast cancerSemantic proximity Read ↗

Co-expression of cytokeratin 8 and breast cancer resistant protein indicates a multifactorial drug-resistant phenotype in human breast cancer cell line.Semantic proximity Read ↗

Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired ChemoresistanceSemantic proximity Read ↗

Metformin resistant MDA-MB-468 cells exhibit EMT-like phenotype and increased migration capacity.Semantic proximity Read ↗

The evaluation of Melatonin and EGF interaction on breast cancer metastasisSemantic proximity Read ↗

EGFR antisense RNA blocks expression of the epidermal growth factor receptor and partially reverse the malignant phenotype of human breast cancer MDA-MB-231 cells.Semantic proximity Read ↗

Development of a human epidermal growth factor derivative with EGFR-blocking and depleted biological activities: A comparative in vitro study using EGFR-positive breast cancer cells.Semantic proximity Read ↗

Expression of the multidrug resistance-associated protein (MRP) and chemoresistance of human non-small-cell lung cancer cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.